Seguir
Lee Hall
Lee Hall
NIAID
Dirección de correo verificada de niaid.nih.gov
Título
Citado por
Citado por
Año
A research agenda to underpin malaria eradication
PL Alonso, G Brown, M Arevalo-Herrera, F Binka, C Chitnis, F Collins, ...
PLoS medicine 8 (1), e1000406, 2011
7562011
The Oxford Companion to the Supreme Court of the United States
KL Hall
Oxford University Press, 2005
4872005
CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages.
RP Da Silva, BF Hall, KA Joiner, DL Sacks
Journal of immunology (Baltimore, Md.: 1950) 143 (2), 617-622, 1989
3291989
Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017
SL James, CD Castle, ZV Dingels, JT Fox, EB Hamilton, Z Liu, ...
Injury Prevention 26 (Suppl 2), i96-i114, 2020
3022020
malERA: an updated research agenda for malaria elimination and eradication
RN Rabinovich, C Drakeley, AA Djimde, BF Hall, SI Hay, J Hemingway, ...
PLoS medicine 14 (11), e1002456, 2017
2592017
Acquisition of murine major histocompatibility complex gene products by schistosomula of Schistosoma mansoni.
A Sher, BF Hall, MA Vadas
Journal of Experimental Medicine 148 (1), 46-57, 1978
2491978
Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes
EH Nardin, GA Oliveira, JM Calvo-Calle, ZR Castro, RS Nussenzweig, ...
The Journal of infectious diseases 182 (5), 1486-1496, 2000
2032000
Desialylation of lysosomal membrane glycoproteins by Trypanosoma cruzi: a role for the surface neuraminidase in facilitating parasite entry into the host cell cytoplasm.
BF Hall, P Webster, AK Ma, KA Joiner, NW Andrews
Journal of experimental medicine 176 (2), 313-325, 1992
1781992
Vaccine technologies: view to the future
NR Rabinovich, P McInnes, DL Klein, BF Hall
Science 265 (5177), 1401-1404, 1994
1671994
Strategies of obligate intracellular parasites for evading host defences
BF Hall, KA Joiner
Immunology Today 12 (3), A22-A27, 1991
1231991
Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-119) and T helper epitopes of …
WA Keitel, KE Kester, RL Atmar, AC White Jr, NH Bond, CA Holland, ...
Vaccine 18 (5-6), 531-539, 1999
1121999
Host-specific evasion of the alternative complement pathway by schistosomes correlates with the presence of a phospholipase C-sensitive surface molecule resembling human decay …
EJ Pearce, BF Hall, A Sher
Journal of immunology (Baltimore, Md.: 1950) 144 (7), 2751-2756, 1990
1101990
Schistosomiasis elimination strategies and potential role of a vaccine in achieving global health goals
AX Mo, JM Agosti, JL Walson, BF Hall, L Gordon
The American journal of tropical medicine and hygiene 90 (1), 54, 2014
94*2014
A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional …
DV Tambourgi, TL Kipnis, WD da Silva, KA Joiner, A Sher, S Heath, ...
Infection and immunity 61 (9), 3656-3663, 1993
871993
Malaria control, elimination, and eradication: the role of the evolving biomedical research agenda
BF Hall, AS Fauci
The Journal of Infectious Diseases 200 (11), 1639-1643, 2009
612009
Malaria vaccine efficacy: the difficulty of detecting and diagnosing malaria
WP O'Meara, BF Hall, FE McKenzie
Malaria journal 6, 1-10, 2007
482007
Trypanosoma cruzi: mechanisms for entry into host cells
BF Hall
Seminars in Cell Biology 4 (5), 323-333, 1993
461993
Characterization of host cell-derived membrane proteins of the vacuole surrounding different intracellular forms of Trypanosoma cruzi in J774 cells. Evidence for phagocyte …
BF Hall, GC Furtado, KA Joiner
Journal of immunology (Baltimore, Md.: 1950) 147 (12), 4313-4321, 1991
451991
Developmentally‐Regulated Virulence Factors of Trypanosoma cruzi and Their Relationship to Evasion of Host Defences1
BF Hall, KA JOINER
Journal of Eukaryotic Microbiology 40 (2), 207-213, 1993
431993
NIAID workshop on immunity to malaria: addressing immunological challenges
AD Augustine, BF Hall, WW Leitner, AX Mo, TM Wali, AS Fauci
Nature immunology 10 (7), 673-678, 2009
332009
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20